Advertisement
Coronavirus vaccine
China

Explainer | How do vaccines and immune systems work, and why could a coronavirus vaccine fail?

  • Six vaccine candidates have reached phase 3 human trials, but it is not uncommon for vaccines to fall at this final hurdle
  • The success of vaccines also comes down to what we expect from them and how long immunity lasts

Reading Time:4 minutes
Why you can trust SCMP
There are 26 potential coronavirus vaccines in various phases of trials. Photo: AFP
Zhuang Pinghui
Anticipation is running high as scientists around the world race to develop a vaccine for Covid-19. Some vaccines showed very promising results in early data. But a vaccine is a highly complicated drug that works on the human body’s complex immune system. We will walk you through the issues to explain how the drug and the human body work, and why a vaccine may not work at all.

What is the immune system? 

It is a complex system of cells, organs and processes that detect foreign substances, including bacteria, viruses, parasites and transplanted organs. The human body counts on the system to detect and identify the foreign substances then develop layers of defence against them.

07:54

Six months after WHO declared Covid-19 a public health emergency, what more do we know now?

Six months after WHO declared Covid-19 a public health emergency, what more do we know now?

How does the immune system work? 

When germs such as bacteria or viruses invade the body, they multiply, causing infection and possible illness. The body can mount a non-specific attempt – called an innate response – to try to eliminate the invaders within hours of an infection. Infections that can be quickly resolved by innate response may not produce symptoms.

When an innate response fails to contain an infection, adaptive response is mounted, usually days later, to fight off the invasion with the help of white blood cells: T-cells and B-cells.

Some types of T-cells identify and kill infected cells. Some help B-cells make antibodies, a kind of protein. A specific type of antibody, called a neutralising antibody, binds to a pathogen and blocks it from entering human cells, thus stopping infection, in a process known as neutralising.

06:17

‘Robust immune responses’ found in Covid-19 vaccine clinical trials point to 2021 release

‘Robust immune responses’ found in Covid-19 vaccine clinical trials point to 2021 release

It is all right for the number of antibodies to decline after a disease is cured, thanks also to T-cells and B-cells. The so-called memory B-cells and T-cells stored in the body can remember the infection and stand by to fight off a similar invasion in future.

How does a vaccine work? 

Vaccines train the immune system to develop a response by mimicking an infection. The process may cause symptoms such as fever, but it also prompts the human body to produce T-cells and antibodies. When the mock infection is over, the body is left with memory T-cells and B-cells that hopefully can remember the infection and mount a defence immediately in the face of a real threat.

How do the Covid-19 vaccines work? 

Scientists around the world are trying to develop vaccines against Sars-CoV-2 – the official name of the coronavirus that causes the disease Covid-19 – using differing technologies.

01:55

Scientists at Oxford University share promising news on coronavirus vaccine trials

Scientists at Oxford University share promising news on coronavirus vaccine trials
Three Chinese developers have used a traditional method by producing vaccines after killing the virus first. Some vaccine candidates (such as Chinese firm CanSino and Oxford University) use genetically engineered adenovirus as a vector to deliver the gene that encodes the spike protein of Sars-CoV-2 into human cells. The spike protein on the surface of Sars-CoV-2 binds to human cells as its means of invasion.
Advertisement
Some vaccine candidates (such as Moderna in the US) use technologies that have never been licensed in vaccines before, by using the platform of nucleic acid and also targeting the S protein. The largest group of candidates use immune-stimulating viral protein antigens.

Are Covid-19 vaccine candidates working? 

Candidates for which data has been published have been shown to induce neutralising antibodies against the spike protein. But whether they offer real protection can be discovered only after large-scale phase 3 trials, which test the broader safety and efficacy of a vaccine.

Advertisement
Select Voice
Choose your listening speed
Get through articles 2x faster
1.25x
250 WPM
Slow
Average
Fast
1.25x